D-1445-2014 Class III Terminated
FDA drug recall D-1445-2014 was initiated by Sandoz Inc on Jul 11, 2014 and is designated Class III. Reason for recall: Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing. The recall status is terminated (terminated Jul 10, 2017). Affected quantity: 781,000 extended release tablets.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 30, 2014
- Initiation Date
- Jul 11, 2014
- Termination Date
- Jul 10, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 781,000 extended release tablets
Product description
Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count bottle, (NDC 0185-0022-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540.
Reason for recall
Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.
Distribution pattern
Nationwide
Code information
Lot # DM1316; Exp. 05/16 Lot # DM1318; Exp. 05/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1445-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026